11.9.26
The health care industry is experiencing profound changes driven by rising medical costs, artificial intelligence (AI), breakthrough pharmaceuticals, an aging population and advances in biotechnology. Hospitals, insurers, pharmaceutical manufacturers and health care providers are investing heavily in technology while struggling to control expenses and improve patient outcomes. At the same time, innovative business models are transforming how medical services are delivered, creating significant opportunities for companies throughout the industry.
Even more information on this industry is available! Check out our Health Care Industry Center.
Plunkett’s Health Care Industry eBook, latest edition.
1. Health Care Spending Continues to Soar
Rising health care expenditures remain one of the industry’s greatest challenges. According to the Centers for Medicare and Medicaid Services (CMS), U.S. health care spending was projected to reach $5.66 trillion in 2025, compared to $5.26 trillion in 2024. Health care represents approximately 18% of U.S. gross domestic product, making it one of America’s largest economic sectors.
Hospital services, physician care and prescription drugs account for much of this spending. Increasing labor costs, expensive medical technologies, hospital consolidation and rising pharmaceutical prices are placing substantial financial pressure on patients, employers and insurers.
Employers are responding by increasing employee contributions toward premiums, deductibles and copayments. Many are also investing in wellness programs, preventive care and workplace clinics to reduce long-term medical expenditures.
2. Artificial Intelligence Revolutionizes Medical Services
AI is rapidly becoming one of the most transformative technologies in health care. Hospitals and physician groups are implementing AI systems to improve diagnostics, automate administrative tasks, analyze medical images and monitor patients.
AI-powered software can identify abnormalities in X-rays, MRIs and CT scans, potentially enabling earlier detection of cancer and other diseases. Generative AI tools are also automating clinical documentation, allowing physicians to spend less time preparing medical records and more time treating patients.
Meanwhile, pharmaceutical companies are applying machine learning to drug discovery, identifying promising compounds and potentially shortening development timelines.
Investment in health care AI continues to accelerate. Companies developing AI-based clinical documentation, administrative automation and diagnostic technologies are attracting substantial venture capital funding.
However, questions surrounding patient privacy, algorithmic accuracy, regulatory oversight and liability remain important challenges.
3. GLP-1 Drugs Transform Obesity Treatment
The emergence of GLP-1 medications represents one of the most significant pharmaceutical breakthroughs in recent years. Drugs including Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound have demonstrated remarkable effectiveness in treating diabetes and obesity.
Clinical studies have shown that certain patients taking these medications can lose approximately 15% to 21% of their body weight, depending on the drug and treatment regimen.
Their potential extends far beyond weight management. Research indicates that GLP-1 medications may help reduce cardiovascular risks, improve kidney health and treat sleep apnea. Scientists are also investigating potential applications involving addiction and other medical conditions.
The development of oral weight-loss medications, additional competing products and lower-cost alternatives could dramatically expand the market. As pharmaceutical manufacturers pursue new treatments, GLP-1 drugs may become among the most commercially important medication categories in history.
4. Aging Baby Boomers Drive Medicare and Long-Term Care Spending
America’s aging population is creating unprecedented demand for medical services. Medicare provided coverage to approximately 69.3 million Americans in 2025, with enrollment projected to exceed 80 million by 2034.
As Baby Boomers grow older, demand is increasing for hospitals, nursing facilities, home health services, prescription medications and chronic disease management.
Older Americans frequently require treatment for multiple chronic conditions, including diabetes, cardiovascular disease, arthritis and dementia. Consequently, Medicare and Medicaid expenditures are placing growing pressure on federal and state budgets.
The aging population is also creating opportunities for companies specializing in assisted living, home-based care, medical devices and remote patient monitoring.
5. Hospitals Consolidate While Value-Based Care Expands
Hospital mergers and acquisitions have transformed the competitive landscape. Large health systems increasingly control substantial regional market shares, while independent physician practices face pressure to join larger organizations.
Consolidation can provide economies of scale, improved technology investments and greater administrative efficiency. However, reduced competition may also contribute to higher medical prices.
Meanwhile, insurers and government programs are encouraging value-based care, which rewards providers for patient outcomes rather than the volume of services performed.
Accountable Care Organizations (ACOs) and other alternative payment arrangements emphasize preventive medicine, coordinated treatment and reduced hospital readmissions.
These approaches could improve quality while helping restrain long-term expenditures.
6. Telemedicine and Alternative Health Care Models Expand
Health care delivery is increasingly moving beyond traditional hospitals and physician offices. Telemedicine, remote patient monitoring, urgent care facilities and outpatient surgical centers are providing more convenient alternatives.
Patients can consult physicians through video appointments, while wearable devices and connected medical equipment allow providers to monitor blood pressure, glucose levels and cardiovascular conditions remotely.
Companies such as Amazon, through One Medical, are expanding their presence in primary care and virtual medical services.
Concierge medicine and direct primary care are also gaining attention. These models typically charge patients membership fees in exchange for more personalized services and improved access to physicians.
For many patients, these alternatives offer greater convenience, although affordability and insurance coverage remain important considerations.
7. Biotechnology and Personalized Medicine Advance
Rapid progress in genetic sequencing, immunotherapy and precision medicine is creating new approaches to treating serious diseases.
Cancer treatment is undergoing particularly significant innovation. CAR-T cell therapies modify patients’ immune cells to attack certain cancers, while antibody-drug conjugates deliver powerful medications directly to targeted cancer cells.
Other emerging technologies, including protein degraders and advanced gene therapies, offer promising approaches to diseases that historically have been difficult to treat.
Meanwhile, declining DNA sequencing costs are making personalized medicine more practical. Physicians increasingly can use genetic information to identify disease risks and select treatments suited to individual patients.
Stem cell research, regenerative medicine and 3D printing are also creating opportunities for tissue repair and potentially more sophisticated medical treatments.
8. Robotics, Advanced Imaging and Digital Records Improve Efficiency
Health care providers are investing in robotic surgery, advanced diagnostic imaging and electronic health records.
Robotic-assisted surgical systems can improve precision and enable minimally invasive procedures, potentially reducing recovery times and hospital stays.
Advanced MRI, PET and CT imaging technologies are improving the detection and monitoring of disease.
Electronic health records enable providers to share patient information more efficiently, while integrated digital systems support improved coordination among hospitals, specialists and insurers.
These technologies require substantial capital investments but offer opportunities to improve productivity and patient care.
9. Health Care Workforce Shortages Create Challenges
Hospitals, nursing facilities and other providers continue to face difficulties recruiting and retaining qualified workers.
Demand for nurses, physicians, technicians and home health aides is increasing as the population ages. Staffing shortages can raise labor expenses, limit available services and contribute to employee burnout.
Health systems are responding through workforce training, automation, improved scheduling and expanded use of technology.
AI-assisted documentation and remote monitoring may help reduce administrative burdens, although technology cannot replace many essential hands-on medical services.
10. The Future
The health care industry offers enormous opportunities for technological innovation and business expansion. Artificial intelligence, biotechnology, GLP-1 medications, robotic surgery and personalized medicine are reshaping the diagnosis and treatment of disease.
At the same time, aging populations, rising insurance premiums, expensive pharmaceuticals and workforce shortages will continue to challenge providers, patients and policymakers.
The industry’s greatest opportunity lies in combining medical breakthroughs with more efficient delivery systems. Companies that successfully improve patient outcomes, expand access to care and control costs will be well positioned to succeed in the rapidly evolving global health care market.
Key Concepts: Biotechnology, business, healthcare, economics, healthcare, entrepreneurship, finance, hospitals, globalization, drugs, innovation, investing, marketing, pharmaceuticals, technology, robotics, artificial intelligence (AI), predictive analytics
Source: Plunkett Research, Ltd., Copyright © 2026
